טוען...
The biological underpinnings of therapeutic resistance in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related mortality in the United States and has only recently achieved a 5-yr survival rate of 10%. This dismal prognosis reflects the remarkable capacity of PDAC to effectively adapt to and resist therapeutic intervention. In this...
שמור ב:
| הוצא לאור ב: | Genes Dev |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cold Spring Harbor Laboratory Press
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8247606/ https://ncbi.nlm.nih.gov/pubmed/34117095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gad.348523.121 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|